Harinder Gill

20PUBLICATIONS
38CO-AUTHORS
Gene and molecular therapyMedical virologyHaematological tumoursPredictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Apr 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

|Mar 24, 2026
Ropeginterferon alfa-2b for prefibrotic myelofibrosis and lower-risk myelofibrosis requiring cytoreduction.

Harinder Gill, Lester Au, Rita Lok Hay Yim

|Feb 27, 2026
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Harinder Gill, Francesca Palandri, David M Ross

|Jul 31, 2025
A clinico-genomic prognostic model for primary myelodysplastic neoplasm in Asia.

Harinder Gill, Rita Yim, Paul Lee

|Jul 17, 2025
Clinical Practice Recommendations for Myelofibrosis Management in the Asia-Pacific Region: The APAC-MF Alliance.

Keita Kirito, Chul Won Choi, Than Hein

|Dec 18, 2024
Acute Promyelocytic Leukemia Asian Consortium study of arsenic trioxide in newly diagnosed patients: impact and outcome.

Harinder Gill, Radha Raghupathy, Hsin-An Hou

Pageof 4

Frequent Collaborators

7 joint publications

Rita Yim

6 joint publications

Paul Lee

5 joint publications

Lynn Chin

4 joint publications

Lester Au